Julian Emanuel, Evercore ISI senior managing director, joins 'Fast Money' to talk the impact of tariffs, uncertainty, and ...

In a report released yesterday, David Motemaden from Evercore ISI maintained a Hold rating on Hartford Financial (HIG – Research Report), with ...

Evercore ISI analyst Amit Daryanani maintained a Buy rating on Dell Technologies (DELL – Research Report) yesterday and set a price target of ...

ESAB Corp (ESAB) stock fell about 2.7% over the past week, but Evercore ISI upgraded the stock to ‘In Line’ from ...

Rich Ross, head of technical analysis at Evercore ISI, said that a breakout to an all-time high in the S&P 500 ( SP500 ), ( ...

Walgreens Chief Executive Officer Tim Wentworth reiterated on an earnings call last month that the company plans to divest ...

Oshkosh (NYSE:OSK – Get Free Report) had its price target boosted by investment analysts at Evercore ISI from $122.00 to $137 ...

W. P. Carey (NYSE:WPC – Get Free Report) had its price objective increased by equities research analysts at Evercore ISI from $60.00 to $64.00 in a note issued to investors on Wednesday,Benzinga ...

For the quarter ended December 2024, Evercore (EVR) reported revenue of $980.5 million, up 25% over the same period last year. EPS came in at $3.41, compared to $2.02 in the year-ago quarter.

Investing.com -- Evercore ISI added Wendy’s Co to its Tactical Outperform list ahead of the company’s investor day on March 6 ...

Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.